Tag Archives: First

UK College of Dentistry hosts its first Day of Dignity – ABC 36 News – WTVQ

LEXINGTON, Ky. (WTVQ) – The College of Dentistry at the University of Kentucky hosted its very own Day of Dignity. A month ago people from the college joined other professionals for a Day of Dignity, providing screenings for the less fortunate, students wanted to take it a step further. – Advertisement – Dentistry volunteers invited… Read More »

Severely injured patient becomes first African American to receive full face transplant

A 68-year-old man from Los Angeles has made medical history by becoming the first African American to receive a full face transplant. In July, Robert Chelsea also became the oldest patient to undergo the surgery, which was performed at Brigham and Women’s Hospital in Boston, NBC News reports. “May God bless the donor and his… Read More »

FDA OKs Trifarotene, First New Retinol Acne Cream in 20 Years – Medscape

The US Food and Drug Administration (FDA) has approved trifarotene cream 0.005% (Aklief, Galderma), the first new retinoid molecule to be approved in the United States in over 20 years for the once-daily topical treatment of acne vulgaris, according to a company news release. Trifarotene is the only topical retinoid that selectively targets retinoic acid… Read More »

Navratri Colours Day 1- Orange: Here’s a Recipe of Gajar Ka Halwa to Celebrate the First Day Dedicated to Goddess Shailaputri

Navratri colours day 1 Recipe Gajar Ka Halwa (Photo Credits: YouTube) Navratri 2019 begins from 29 September and will last till October 7. The nine-night festival is also known as Durga Utsav or Durga Puja in some states of India is one of the most awaited celebrations of India. Each day of the festival is… Read More »

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes

FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes Print this page PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that… Read More »